Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
Okada M, Kita Y, Nakajima T, Hashimoto S, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC. Okada M, et al. Among authors: nishimatsu s. Hum Vaccin Immunother. 2013 Mar;9(3):515-25. doi: 10.4161/hv.23229. Epub 2012 Dec 18. Hum Vaccin Immunother. 2013. PMID: 23249543 Free PMC article.
Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y, Okada M, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Takamori Y, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M. Kita Y, et al. Among authors: nishimatsu s. Hum Vaccin. 2011 Jan-Feb;7 Suppl:108-14. doi: 10.4161/hv.7.0.14571. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21263229
Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis.
Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, McMurray DN, Sakatani M. Okada M, et al. Among authors: nishimatsu s. Clin Dev Immunol. 2011;2011:549281. doi: 10.1155/2011/549281. Epub 2011 Mar 7. Clin Dev Immunol. 2011. PMID: 21437226 Free PMC article.
Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Matsumoto M, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M. Okada M, et al. Among authors: nishimatsu s. Hum Vaccin. 2011 Jan-Feb;7 Suppl:60-7. doi: 10.4161/hv.7.0.14563. Hum Vaccin. 2011. PMID: 21546794
Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
Kita Y, Hashimoto S, Nakajima T, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC, Okada M. Kita Y, et al. Among authors: nishimatsu s. Hum Vaccin Immunother. 2013 Mar;9(3):526-33. doi: 10.4161/hv.23230. Epub 2012 Dec 18. Hum Vaccin Immunother. 2013. PMID: 23249609 Free PMC article.
A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Nagasawa T, Kaneda Y, Yoshida S, Matsumoto M, Paul S, Tan EV, Cruz ECD, N McMurray D, Sakatani M. Okada M, et al. Among authors: nishimatsu s. Procedia Vaccinol. 2010;2(1):34-39. doi: 10.1016/j.provac.2010.03.007. Epub 2010 Apr 14. Procedia Vaccinol. 2010. PMID: 32288910 Free PMC article.
Circulating α-Klotho Counteracts Transforming Growth Factor-β-Induced Sarcopenia.
Ohsawa Y, Ohtsubo H, Munekane A, Ohkubo K, Murakami T, Fujino M, Nishimatsu SI, Hagiwara H, Nishimura H, Kaneko R, Suzuki T, Tatsumi R, Mizunoya W, Hinohara A, Fukunaga M, Sunada Y. Ohsawa Y, et al. Among authors: nishimatsu si. Am J Pathol. 2023 May;193(5):591-607. doi: 10.1016/j.ajpath.2023.01.009. Epub 2023 Feb 10. Am J Pathol. 2023. PMID: 36773783 Free article.
Caveolin 3 suppresses phosphorylation-dependent activation of sarcolemmal nNOS.
Ohsawa Y, Ohtsubo H, Saito Y, Nishimatsu SI, Hagiwara H, Murakami T, Nishino I, Sunada Y. Ohsawa Y, et al. Among authors: nishimatsu si. Biochem Biophys Res Commun. 2022 Nov 5;628:84-90. doi: 10.1016/j.bbrc.2022.08.066. Epub 2022 Aug 27. Biochem Biophys Res Commun. 2022. PMID: 36084555 Free article.
77 results